Surveillance of catheter-related infections: the supplementary role of the microbiology laboratory.

Wilhelmina Strasheim, Martha M Kock, Veronica Ueckermann, Ebrahim Hoosien, Andries W Dreyer, Marthie M Ehlers
Author Information
  1. Wilhelmina Strasheim: Department of Medical Microbiology, University of Pretoria, Pretoria, South Africa. wilkestrasheim@gmail.com.
  2. Martha M Kock: Department of Medical Microbiology, University of Pretoria, Pretoria, South Africa. marleen.kock@up.ac.za.
  3. Veronica Ueckermann: Department of Internal Medicine, University of Pretoria, Pretoria, South Africa. ueckermannv@live.com.
  4. Ebrahim Hoosien: National Health Laboratory Service, Tshwane Academic Division, Pretoria, South Africa. ebbsterus@yahoo.com.
  5. Andries W Dreyer: Centre for Tuberculosis, National Institute of Communicable Diseases, Johannesburg, South Africa. aw.dreyer@gmail.com.
  6. Marthie M Ehlers: Department of Medical Microbiology, University of Pretoria, Pretoria, South Africa. marthie.ehlers@up.ac.za.

Abstract

BACKGROUND: The burden of catheter-related infections (CRIs) in developing countries is severe. In South Africa, a standardised surveillance definition does not exist and the collection of catheter days is challenging. The aim of the study was to provide baseline data on the prevalence of CRIs and to describe the epidemiology of CRI events within a tertiary academic hospital.
METHODS: Surveillance was laboratory-based and conducted for a six month period. A microbiologically confirmed CRBSI (MC-CRBSI) event was defined as the isolation of the same microorganism from the catheter and concomitant blood cultures (BCs), within 48 h of catheter removal, which were not related to an infection at another site.
RESULTS: A total of 508 catheters, removed from 332 patients, were processed by the laboratory, of which only 50% (253/508 removed from 143/332 patients) of the catheters were accompanied by BCs within 48 h. Sixty-five episodes of MC-CRBSI in 57 patients were detected, involving 71 catheters and 195 microbial isolates. The institutional prevalence rate was 3.7 episodes per 1 000 admissions and 5.8 episodes per 10 000 in-patient days. Catheter day data was collected in only six wards of the hospital. The pooled laboratory incidence was 10.1 MC-CRBSI episodes per 1 000 catheter days, whereas the hospital-based central line-associated bloodstream infection (CLABSI) rate was pooled at 5.7 episodes per 1 000 catheter days. The majority of patients had an underlying gastro-intestinal condition (33%; 19/56) with a non-tunnelled, triple-lumen central venous catheter, placed in the subclavian vein (38%; 27/71). The most predominant pathogen was methicillin-resistant Staphylococcus epidermidis (28%; 55/195), followed by extensively-drug resistant Acinetobacter baumannii (18%; 35/195).
CONCLUSIONS: Catheter-related infection prevention and control efforts require urgent attention, not only to keep patients safe from preventable harm, but to prevent the spread of multidrug resistant microorganisms.

References

  1. S Afr Med J. 2007 Dec;97(12 Pt 3):1315-8 [PMID: 18265912]
  2. Clin Infect Dis. 2012 Aug;55(3):364-70 [PMID: 22539665]
  3. Infect Control Hosp Epidemiol. 2013 Jan;34(1):1-14 [PMID: 23221186]
  4. J Hosp Infect. 2013 Dec;85(4):257-67 [PMID: 24209885]
  5. Int J Nurs Stud. 2013 Feb;50(2):162-73 [PMID: 23218020]
  6. Eur J Clin Microbiol Infect Dis. 2001 Sep;20(9):617-25 [PMID: 11714042]
  7. Clin Microbiol Infect. 2012 Mar;18(3):268-81 [PMID: 21793988]
  8. J Antimicrob Chemother. 2012 Jul;67(7):1607-15 [PMID: 22441575]
  9. N Engl J Med. 1977 Jun 9;296(23):1305-9 [PMID: 323710]
  10. Clin Infect Dis. 2009 Jul 1;49(1):1-45 [PMID: 19489710]
  11. J Hosp Infect. 2013 Dec;85(4):316-20 [PMID: 24183319]
  12. Am J Infect Control. 2014 Sep;42(9):942-56 [PMID: 25179325]
  13. Infect Control Hosp Epidemiol. 2013 Sep;34(9):893-9 [PMID: 23917902]
  14. Am J Infect Control. 2014 Feb;42(2):116-21 [PMID: 24485368]
  15. Clin Microbiol Infect. 2013 Sep;19(9):845-51 [PMID: 23565810]
  16. Am J Infect Control. 2012 Jun;40(5):396-407 [PMID: 21908073]
  17. J Antimicrob Chemother. 2011 Sep;66(9):2119-25 [PMID: 21665905]
  18. Lancet. 2011 Jan 15;377(9761):228-41 [PMID: 21146207]
  19. Am J Infect Control. 2008 Nov;36(9):e1-12 [PMID: 18992646]
  20. S Afr Med J. 2011 Jul 28;101(8 Pt 2):587-95 [PMID: 21920138]
  21. Antimicrob Resist Infect Control. 2013 Apr 03;2(1):10 [PMID: 23551847]
  22. Infect Control Hosp Epidemiol. 2010 Apr;31(4):418-20 [PMID: 20175684]
  23. Clin Microbiol Infect. 2014 Oct;20(10):O627-9 [PMID: 24461043]
  24. Enferm Infecc Microbiol Clin. 2012 Dec;30(10):613-7 [PMID: 22446007]
  25. Clin Infect Dis. 2011 May;52(9):e162-93 [PMID: 21460264]
  26. J Hosp Infect. 2013 Mar;83(3):238-43 [PMID: 23394814]
  27. Am J Infect Control. 2007 Sep;35(7):427-40 [PMID: 17765554]
  28. Infect Control Hosp Epidemiol. 2010 Dec;31(12):1264-72 [PMID: 21029008]
  29. J Hosp Infect. 2009 Dec;73(4):355-63 [PMID: 19700220]

MeSH Term

Actinobacteria
Adolescent
Adult
Africa South of the Sahara
Catheter-Related Infections
Child
Child, Preschool
Female
Humans
Iatrogenic Disease
Incidence
Infant
Infant, Newborn
Male
Methicillin Resistance
Methicillin-Resistant Staphylococcus aureus
Middle Aged
Risk Factors
Staphylococcus epidermidis
Young Adult

Word Cloud

Created with Highcharts 10.0.0catheterpatientsepisodesdaysper1000withinMC-CRBSIinfectioncatheterslaboratorycatheter-relatedCRIsdataprevalencehospitalSurveillancesixBCs48hremovedrate7510pooledcentralresistantBACKGROUND:burdeninfectionsdevelopingcountriessevereSouthAfricastandardisedsurveillancedefinitionexistcollectionchallengingaimstudyprovidebaselinedescribeepidemiologyCRIeventstertiaryacademicMETHODS:laboratory-basedconductedmonthperiodmicrobiologicallyconfirmedCRBSIeventdefinedisolationmicroorganismconcomitantbloodculturesremovalrelatedanothersiteRESULTS:total508332processed50%253/508143/332accompaniedSixty-five57detectedinvolving71195microbialisolatesinstitutional3admissions8in-patientCatheterdaycollectedwardsincidencewhereashospital-basedline-associatedbloodstreamCLABSImajorityunderlyinggastro-intestinalcondition33%19/56non-tunnelledtriple-lumenvenousplacedsubclavianvein38%27/71predominantpathogenmethicillin-resistantStaphylococcusepidermidis28%55/195followedextensively-drugAcinetobacterbaumannii18%35/195CONCLUSIONS:Catheter-relatedpreventioncontroleffortsrequireurgentattentionkeepsafepreventableharmpreventspreadmultidrugmicroorganismsinfections:supplementaryrolemicrobiology

Similar Articles

Cited By